Alpha 2.0
Login Register
» Articles » PMID: 35092958

Analysis of the Excess of Papanicolaou Tests in Brazil from 2006 to 2015

Overview
Journal Rev Bras Ginecol Obstet
Specialty Gynecology & Obstetrics
Date 2022 Jan 29
PMID 35092958
Authors
Ana Carolina Pereira Fischer
Eduardo Augusto Pereira Fischer
Fernanda Briao Vaz
Julia Hoffmann
Affiliations
Soon will be listed here.
Abstract

Objective:  To analyze the quantity of cervical smears, also designated Papanicolaou tests, between 2006 and 2015 in all the Federal units of Brazil, as well as to verify the quantity of exams collected outside the recommended age range and the economic impact of such excess.

Methods:  The data was collected from the Ministry of Health's database called (SISCOLO), which contains all the test results collected nationwide by the Unified Health System (SUS, in the Portuguese acronym). From that, the number of exams and the age range of the women who underwent them were analyzed; besides, these numbers were stratified according to the state of where the exam was performed. The quantity of exams collected outside the recommended age range was verified, and, so, the economic impact generated was noted.

Results:  Between 2006 and 2015, 87,425,549 Papanicolaou tests were collected in Brazil. Of these, 20,215,052 tests were collected outside the age range recommended by the Brazilian Ministry of Health; this number corresponded to 23.12% of all exams. From such data, considering that each Pap smear collected by SUS generates a cost of BRL 7.30 to the government, according to the information in the dated September 2018, there was a total charge of BRL 147,569,880 for tests collected outside the protocol.

Conclusion:  In Brazil, according to the Ministry of Health's protocol about the recommended practices on collecting Pap smears, whose newest edition dates of 2016, it is recommended that Pap smears are collected in women from a specific age range, in whom the potential diagnosing advantages overcome the onus of overdiagnosis or of a lesion with great regression potential. However, such protocols have not been correctly followed, promoting more than 20 million tests in excess, and an exorbitant cost for the Brazilian public health system. It is relevant to take measures to correctly use the official protocol, reducing the patients risks, as well as the economic impact for SUS.

References
1.
Silveira N, Vasconcelos C, Nicolau A, Oria M, Pinheiro P, Pinheiro A . Knowledge, attitude and practice of the smear test and its relation with female age. Rev Lat Am Enfermagem. 2016; 24. PMC: 4916975. DOI: 10.1590/1518-8345.0700.2699. View
2.
de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N . Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007; 7(7):453-9. DOI: 10.1016/S1473-3099(07)70158-5. View
3.
Rico A, Iriart J . ["Where there's a woman, there's a Pap smear": the meanings assigned to cervical cancer prevention among women in Salvador, Bahia State, Brazil]. Cad Saude Publica. 2013; 29(9):1763-73. DOI: 10.1590/0102-311x00146512. View
4.
Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2011; 127(12):2893-917. DOI: 10.1002/ijc.25516. View
5.
Vale D, Morais S, Pimenta A, Zeferino L . [Assessment of the cervical cancer screening in the Family Health Strategy in Amparo, São Paulo State, Brazil]. Cad Saude Publica. 2010; 26(2):383-90. DOI: 10.1590/s0102-311x2010000200017. View